Nicola Mikulcik Ohrner
Corporate Officer/Principal chez FORMYCON AG
Postes actifs de Nicola Mikulcik Ohrner
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FORMYCON AG | Corporate Officer/Principal | 01/06/2022 | - |
bioeq GmbH
 bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Directeur Général | - | - |
Bioeq AG
 Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Nicola Mikulcik Ohrner
Statistiques
Internationale
| Allemagne | 3 |
| Suisse | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Bioeq AG
Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Health Technology |
bioeq GmbH
bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Health Technology |
- Bourse
- Insiders
- Nicola Mikulcik Ohrner
- Expérience
